Skip to main content

North America to Dominate the Robotic Surgery Consumables Market with Maximum Market Share

 

Robotic surgery consumables may be defined as those instruments and accessories which are used with computer-assisted surgical systems. The equipment help the surgeons perform safe, precise, and accurate surgical procedures. Robotic surgery consumables include instruments such as scissors, forceps, and other tools. These instruments, in most cases, are specially manufactured by surgical robotic system manufacturers.

The instruments are designed in such a manner that they are able to perform a safe and minimally invasive surgical (MIS) procedure. Certain consumables, such as graspers and forceps, can be reused. They can be re-used for more than one surgery. However, they must be replaced after a certain number of procedures have been performed, as per specifications provided by the original equipment manufacturer (OEM).

The global robotic surgery consumables market is estimated to be valued at $2,831.7 million in 2019 and is projected to register a CAGR of 11.37%. The growth in the robotic surgery consumables market is mainly attributed to a faster rate of adoption of surgical robotic systems. Surgical robotic technology has significant benefits over conventional surgery in improving the efficacy and precision of procedures.

The global robotic surgery consumables market has been segmented into seven core categories on the basis of application – urology, gynecology, general surgery, cardiology, orthopedic surgery, head, and neck surgical procedure and other surgical procedures.

The share of the general surgery application in terms of value in the robotic surgery consumables market for the year 2018 is 27.57% and is the highest contributor to the market. The general surgery is expected to account for more than 45% of the total market by application, by the end of 2030. The growth rate that the gynecology segment is expected to register is around 5.79% during the forecast period.

The global robotic surgery consumables market has been segmented into three core categories on the basis of end-use – hospitals, ambulatory surgical centers (ASCs), and others (research institutions and specialty clinics). The advancement in technology in the healthcare robotics space is expected to play a key role in propelling growth in the adoption of robotic surgery systems. The increase in patient awareness and acceptance for advanced surgical technologies coupled with increasing disposable income is expected to lead to a rise in healthcare expenditure in the coming years.

Lastly, the potential of robotic surgery consumables market with respect to different regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Rest-of-the-World (ROW), has been described in this section.

In 2018, the contribution of North America was valued to be 66.52% of the total share of the market. The region is expected to contribute 45.69% of global market value in 2030. Substantial investments made by leading companies, such as Medtronic plc, Medrobotics Corporation, and Auris Health, Inc. in the field of surgical robotics play a pivotal role in the growth of the North America robotic surgery consumables market.

Labels:

Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

High-End Synthetic Suede Market Latest Trend, Industry Growth, Competitive Analysis Upto 2031

High-end synthetic suede has been able to mark its presence in the fashion industry as well. Global fashion designers, with an aim to inculcate sustainability, have started to incorporate synthetic materials in their production process, to not only achieve sustainability but also to send a strong message to their customers regarding the proliferated use of vegan materials. The growth in the high-end synthetic suede market is attributable to increasing demand from the automotive industry and the need for a replacement of natural suede. Synthetic suede is made through the blends of polyester and other plastics, posing less environmental hazard just like natural suede does. Synthetic suede is typically more economical and affordable as compared to natural suede. The material is highly durable and requires low maintenance, which has made it a popular choice as a replacement of natural suede. The increase in the number of end-use industries, rise in the demand for a replacement of natural s...
Post a Comment
Read more

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Post a Comment
Read more